NIH-funded research R01 grant

Increasing access to harm reduction services through mail delivery in the U.S.

Official title: Expansion of Mail-Delivered Harm Reduction Services in the U.S.

Funded at Weill Medical Coll of Cornell Univ · NIH-10590378 · Data updated 2026-11-12

This study is looking to make it easier for people to get important harm reduction supplies, like syringes and naloxone, by exploring how mail delivery can help, and it’s for anyone who might need these resources to stay safe and healthy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2025
Funding year2022
Award (this year)$2,393,373
NIH project number1R01DA057654-01
Project IDNIH-10590378 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who use injectable drugs or are at risk of opioid overdose and are seeking harm reduction services.

Less likely to help

Patients who do not use injectable drugs or are not at risk of opioid overdose may not benefit from this research.

What this research studies

This research aims to improve access to harm reduction services, such as syringes and naloxone, by expanding mail delivery options. It will investigate the legal barriers to distributing these services across the U.S. and conduct a national study to understand how individuals engage with mail-based harm reduction. By surveying stakeholders and potential users, the project seeks to identify preferences and challenges in accessing these critical health resources. The goal is to create a more convenient and confidential way for individuals to obtain harm reduction supplies.

Why it matters

Potential benefit: If successful, this research could significantly reduce overdose deaths and prevent the spread of HIV and hepatitis C among at-risk populations.

How similar studies have gone: Previous research has shown that mail-based harm reduction services can effectively increase access to essential health supplies, indicating a promising approach.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Behrends, Czarina Navos — Weill Medical Coll of Cornell Univ
  • Study coordinator: Behrends, Czarina Navos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.